B&K (HKSE:02396) Total Liabilities: HK$65.91 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02396 B&K Corp Ltd HKSE:02396
8 GF Score
Price HK$4.40
! 1 Warning Sign
View Full Analysis

What is B&K Total Liabilities?

B&K HKSE:02396 8 Total Liabilities is HK$65.91 Mil as of Dec. 2025. GuruFocus rates HKSE:02396 with a GF Score™ of 8/100. The stock has 1 warning sign investors should review.

B&K's Total Liabilities for the quarter that ended in Dec. 2025 was HK$65.91 Mil.

B&K's quarterly Total Liabilities declined from May. 2025 (HK$49.79 Mil) to Sep. 2025 (HK$47.45 Mil) but then increased from Sep. 2025 (HK$47.45 Mil) to Dec. 2025 (HK$65.91 Mil).

B&K's annual Total Liabilities declined from Dec. 2023 (HK$432.00 Mil) to Dec. 2024 (HK$42.79 Mil) but then increased from Dec. 2024 (HK$42.79 Mil) to Dec. 2025 (HK$65.91 Mil).

B&K Total Liabilities Historical Data

* Premium members only.

The historical data trend for B&K's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

B&K Total Liabilities Chart

B&K Annual Data
Trend Dec23 Dec24 Dec25
Total Liabilities
432.00 42.79 65.91

B&K Quarterly Data
Dec23 Dec24 May25 Sep25 Dec25
Total Liabilities 432.00 42.79 49.79 47.45 65.91
HKSE:02396
8GF Score
B&K Corp Ltd HKSE:02396
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

B&K Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

B&K's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=41.066+(0.064+-7.105427357601E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+24.78)
=65.91

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=755.903-689.993
=65.91

B&K's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=41.066+(0.064+-7.105427357601E-15
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+24.78)
=65.91

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=755.903-689.993
=65.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of HK$65.91 Mil mean?
B&K (HKSE:02396) has a Total Liabilities of HK$65.91 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for B&K and its competitors.
Is B&K's Total Liabilities too high?
B&K's current Total Liabilities is HK$65.91 Mil. Overall, B&K has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does B&K's Total Liabilities compare to VRTX and REGN?
B&K's Total Liabilities of HK$65.91 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for B&K and its competitors. B&K's current Total Liabilities is HK$65.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is B&K stock overvalued right now?
B&K (HKSE:02396) has a current Total Liabilities of HK$65.91 Mil. The current Total Liabilities is HK$65.91 Mil. B&K's overall GF Score™ is 8/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For B&K (HKSE:02396), the current Total Liabilities is HK$65.91 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

B&K Business Description

Address No. 19 Qinling Road, Xiexin Center, Room 1507, Building 1, Laoshan District, Shandong Province, Qingdao, CHN
B&K Corp Ltd is a China-based biopharmaceutical company committed to developing therapies with an emphasis on protein drugs for indications with medical needs and market opportunities. The company prominently focuses on the discovery, development and commercialization of therapies for wound healing, currently PDGF drugs. Its pipeline consisted of ten candidates, seven of which are PDGF candidates, including two Core Products, namely Pro-101-1 for the treatment of thermal burns and Pro-101-2 for the treatment of DFUs, which are rhPDGF-BB drugs. The company operates in a single reportable segment: the research and development of biopharmaceutical products. Geographically, the company generates all its revenue from Chinese Mainland.
8GF Score

Get the complete analysis for HKSE:02396

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$4.40
Price